Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan.
Department of Hematology, Ichinomiya Nishi Hospital, Ichinomiya, Japan.
J Clin Exp Hematop. 2024 Sep 28;64(3):252-260. doi: 10.3960/jslrt.24033. Epub 2024 Aug 30.
MYD88 p.L265P mutation occurs in over 90% of Waldenström's macroglobulinemia (WM), which is characterized by lymphoplasmacytic lymphoma (LPL) with monoclonal IgM. WM requires careful diagnosis due to overlapping features with other B-cell malignancies. Bing-Neel syndrome (BNS), a rare complication of WM, involves central nervous system (CNS) invasion. This report describes two cases of morphologically low-grade B-cell lymphoma in the bone marrow accompanied by the presence of a large B-cell lymphoma in the brain and a common MYD88 p.L265P mutation, which were eventually established as BNS mimickers. Although the two components in these cases showed the same identical light-chain restriction, different immunoglobulin heavy-chain rearrangement peaks indicated distinct lymphoma stem cells for CNS and bone marrow lesions. These clinical cases emphasize the challenges in diagnosing BNS. Based on the findings, biopsy is recommended for accurate identification of the clonal relationship and MYD88 mutation status.
MYD88 p.L265P 突变发生在超过 90%的华氏巨球蛋白血症(WM)中,其特征为单克隆 IgM 的淋巴浆细胞淋巴瘤(LPL)。WM 需要仔细诊断,因为其与其他 B 细胞恶性肿瘤有重叠特征。Bing-Neel 综合征(BNS)是 WM 的一种罕见并发症,涉及中枢神经系统(CNS)侵犯。本报告描述了两例骨髓中形态学低度恶性 B 细胞淋巴瘤伴有脑内大 B 细胞淋巴瘤和常见的 MYD88 p.L265P 突变,最终被确定为 BNS 模拟物。尽管这两个病例的两个成分表现出相同的轻链限制,但不同的免疫球蛋白重链重排峰表明 CNS 和骨髓病变的淋巴瘤干细胞不同。这些临床病例强调了诊断 BNS 的挑战。基于这些发现,建议进行活检以准确识别克隆关系和 MYD88 突变状态。